|
 |
|
LETTER TO THE EDITOR |
|
|
|
| Year : 2020 | Volume
: 23
| Issue : 7 | Page : 43-44 |
| |
COVID-19 and underlying cerebrovascular disease: Analysis on association
Pathum Sookaromdee1, Viroj Wiwanitkit2
1 TWS Medical Center, Bangkok, Thailand
2 Honorary Professor, Dr DY Patil University, Pune, India; Visiting Professor, Hainan Medical University, Haikou, China
| Date of Submission | 09-Apr-2020 |
| Date of Decision | 09-Apr-2020 |
| Date of Acceptance | 06-Apr-2020 |
| Date of Web Publication | 17-Apr-2020 |
Correspondence Address:
Pathum Sookaromdee
TWS Medical Center, Bangkok
Thailand
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aian.AIAN_280_20
How to cite this article:
Sookaromdee P, Wiwanitkit V. COVID-19 and underlying cerebrovascular disease: Analysis on association. Ann Indian Acad Neurol 2020;23, Suppl S1:43-4 |
Dear Editor,
COVID-19 is a new emerging viral disease that can cause severe respiratory distress. The first patient was reported in Wuhan within the Republic of China,[1] before the disease widespread around the world. The underlying illness is reported for association with severity of COVID-19. Regarding cerebrovascular disease, a Chinese report showed that it is a risk factor for severe COVID-19 infection.[2]
Here, the author would like to present additional data from the second country that the new disease had occurred since early January 2020, Thailand.[3] At present (8th April 2020), the total number of COVID-19 patients with 30 deaths in Thailand is 2,369. Two (0.08%) from all COVID-19 patients have underlying cerebrovascular diseases. Focusing on association between underlying cerebrovascular disease and mortality [Table 1]. The preliminary observation from our setting did not support the association between having underlying cerebrovascular disease and poor outcome of COVID-19. Further analysis based on more data from international settings is recommended to clarify the exact clinical relationship between COVID-19 and cerebrovascular disease. | Table 1: Association between underlying cerebrovascular disease and mortality
Click here to view |
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
 References | |  |
| 1. | Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.  |
| 2. | Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: Evidence from meta-analysis. Aging (Albany NY). 2020 Apr 8;12. doi: 10.18632/aging. 103000. [Epub ahead of print]. |
| 3. | Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2. |
[Table 1]
|
